← Browse by Condition
Medical Condition

advanced or metastatic esophageal cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06474468 Phase 1, Phase 2
Recruiting

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer

Enrollment
148 pts
Location
China
Sponsor
Shanghai Hengrui Pharmaceutica...
View Trial →